Ovid Therapeutics(DE:1OT)
€2.38+0.18 (+8.18%)
DE:1OT
Ovid Therapeutics earnings date
€2.38
At close:+0.18 (+8.18%)
Ovid Therapeutics (1OT) Q2 2018 Earnings Report
6 Followers
DE:1OT Q2 2018 EPS Results
- Actual EPS
- -EUR 0.48
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -EUR 0.52
DE:1OT Q2 2018 Revenue Results
- Actual Revenue
- EUR 0
- Expected Revenue
- ―
- Beat/Miss
- ―
- YoY Revenue Growth
- ―
Earnings Announcement Details
- Quarter
- Q2 2018
- Date
- 08/09/2018
- Time
- TBA
- Conference Call
- Thursday, August 9, 2018
DE:1OT Upcoming Earnings
Ovid Therapeutics's next earnings date is estimated for March 15, 2027, based on past reporting schedules.
Q2 2018 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2018 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2018 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:1OT Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 15, 2027 | 2026 (Q4) | -0.10- | 0.05 | ― | ― |
| Nov 10, 2026 | 2026 (Q3) | -0.08-0.09 | -0.15 | 41.18% (+0.06) | |
| Aug 13, 2026 | 2026 (Q2) | -0.10-0.07 | -0.05 | -33.33% (-0.02) | |
| May 12, 2026 | 2026 (Q1) | -0.11-0.11 | -0.13 | 14.29% (+0.02) | |
| Mar 18, 2026 | 2025 (Q4) | -0.110.05 | -0.12 | 146.15% (+0.17) | |
| Nov 12, 2025 | 2025 (Q3) | -0.14-0.15 | -0.18 | 15.00% (+0.03) | |
| Aug 13, 2025 | 2025 (Q2) | -0.14-0.05 | 0.11 | -150.00% (-0.16) | |
| May 13, 2025 | 2025 (Q1) | -0.13-0.13 | -0.15 | 17.65% (+0.03) | |
| Mar 11, 2025 | 2024 (Q4) | -0.15-0.12 | -0.2 | 40.91% (+0.08) | |
| Nov 12, 2024 | 2024 (Q3) | -0.19-0.18 | -0.15 | -25.00% (-0.04) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

